List of bibliographic references
Number of relevant bibliographic references: 7.
| Ident. | Authors (with country if any) | Title |
|---|
| 000508 (2017) |
Buranee Kanchanatawan [Thaïlande] ; Solaphat Hemrungrojn [Thaïlande] ; Supaksorn Thika [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; George Anderson [Royaume-Uni] ; Michael Maes [Thaïlande] | Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia. |
| 000749 (2017) |
Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Supaksorn Thika [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; George Anderson [Royaume-Uni] ; Cristiano Noto [Brésil] ; Rada Ivanova [Bulgarie] ; Michael Maes [Thaïlande] | Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway. |
| 000B30 (2017) |
Jean-Marc Steens [France] ; Didier Scherrer [France] ; Paul Gineste [Oman] ; P Noel Barrett [France] ; Supparatpino Khuanchai [Thaïlande] ; Ratanasuwan Winai [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; Jamal Tazi [France] ; Robert Murphy [États-Unis] ; Hartmut Ehrlich [France] | Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study. |
| 000F25 (2017) |
Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; George Anderson [Royaume-Uni] ; Michael Maes [Thaïlande] | Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation. |
| 001137 (2017) |
Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; Heidi Ormstad [Norvège] ; George Anderson [Royaume-Uni] ; Michael Maes [Thaïlande] | Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid. |
| 001B82 (2016) |
Sarah Lilian Pett [Royaume-Uni] ; Janaki Amin [Australie] ; Andrejz Horban [Pologne] ; Jaime Andrade-Villanueva [Mexique] ; Marcelo Losso ; Norma Porteiro [Argentine] ; Juan Sierra Madero [Mexique] ; Waldo Belloso [Argentine] ; Elise Tu [Australie] ; David Silk [Australie] ; Anthony Kelleher [Australie] ; Richard Harrigan [Canada] ; Andrew Clark [Royaume-Uni] ; Wataru Sugiura [Japon] ; Marcelo Wolff [Chili] ; John Gill [Canada] ; Jose Gatell [Espagne] ; Martin Fisher [Royaume-Uni] ; Amanda Clarke [Royaume-Uni] ; Kiat Ruxrungtham ; Thierry Prazuck [France] ; Rolf Kaiser [Allemagne] ; Ian Woolley [Australie] ; Juan Alberto Arnaiz [Espagne] ; David Cooper [Australie] ; Jürgen K. Rockstroh [Allemagne] ; Patrick Mallon [Irlande (pays)] ; Sean Emery [Australie] | Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. |
| 002F58 (2015) |
Mark A. Boyd [Australie] ; Cecilia L. Moore [Australie] ; Jean-Michel Molina [France] ; Robin Wood [Afrique du Sud] ; Juan S. Madero [Mexique] ; Marcelo Wolff [Chili] ; Kiat Ruxrungtham [Thaïlande] ; Marcelo Losso [Argentine] ; Boris Renjifo [États-Unis] ; Hedy Teppler [États-Unis] ; Anthony D. Kelleher [Australie] ; Janaki Amin [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie] | Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Kiat Ruxrungtham"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i \
-Sk "Kiat Ruxrungtham" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= indexItem
|index= Author.i
|clé= Kiat Ruxrungtham
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
